CGC logoCGC
Canopy Growth Corp

93,748
Loading...
Loading...
News
all
press releases
FDA Identifies ICU Medical's Plum Duo Recall as Serious Type
ICUI faces an FDA recall of its Plum Duo Infusion System over software flaws, though devices remain in use, pending fixes.
Zacks·6d ago
News Placeholder
More News
News Placeholder
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks·10d ago
News Placeholder
3 Cannabis Stocks to Watch After Trump's Marijuana Rescheduling Signal
Trump's marijuana rescheduling remarks reignite cannabis optimism, putting Village Farms, Canopy Growth and High Tide in focus.
Zacks·16d ago
News Placeholder
Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks·24d ago
News Placeholder
Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification
Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.
Zacks·26d ago
News Placeholder
Trump Confirms Marijuana Reclassification Decision To Be Made In ‘Next Few Weeks’
The President noted that there’s a difference of opinion on the benefits of marijuana, but added that he’s heard “great things” with respect to medical marijuana, specifically.
Stocktwits·27d ago
News Placeholder
Retail Bulls Pile Into Cannabis Stocks On Reports Trump May Reclassify Marijuana; Traders Eye Aurora Rally
Cannabis firms have spent millions lobbying Trump to shift marijuana to Schedule III, easing restrictions and enabling tax breaks.
Stocktwits·28d ago
News Placeholder
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
Zacks·1mo ago
News Placeholder
Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates
Canopy Growth (CGC) delivered earnings and revenue surprises of +6.67% and +8.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates
Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of -5.94% and -4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago

Latest CGC News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.